Sorrell et al., 2009 - Google Patents
National Institutes of Health consensus development conference statement: management of hepatitis BSorrell et al., 2009
View HTML- Document ID
- 5036842006154836139
- Author
- Sorrell M
- Belongia E
- Costa J
- Gareen I
- Grem J
- Inadomi J
- Kern E
- McHugh J
- Petersen G
- Rein M
- Strader D
- Trotter H
- Publication year
- Publication venue
- Annals of internal medicine
External Links
Snippet
Vaccines for hepatitis B virus have resulted in a substantial decline in the number of new cases of acute hepatitis B in the United States, but this success has not yet been duplicated worldwide. To more closely examine this topic, the National Institutes of Health (NIH) …
- 208000002672 Hepatitis B 0 title abstract description 67
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation, e.g. computer aided management of electronic mail or groupware; Time management, e.g. calendars, reminders, meetings or time accounting
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sorrell et al. | National Institutes of Health consensus development conference statement: management of hepatitis B | |
Hatzakis et al. | The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference | |
Cuadrado et al. | Microenvironment eradication of hepatitis C: a novel treatment paradigm | |
Falade-Nwulia et al. | Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review | |
Lee et al. | Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study | |
Strom et al. | Eliminating the public health problem of hepatitis B and C in the United States: phase one report | |
Scaglione et al. | Effectiveness of hepatitis B treatment in clinical practice | |
Seeff et al. | The National Institutes of Health Consensus Development Conference: Management of Hepatitis C 2002 | |
Aleman et al. | A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C–associated liver cirrhosis | |
Afdhal et al. | The new paradigm of hepatitis C therapy: integration of oral therapies into best practices | |
Janssen et al. | Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial | |
Lo Re III et al. | Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study | |
Spradling et al. | Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996–2007 | |
Lee et al. | Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991–2 | |
Grint et al. | Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA | |
Stepanova et al. | Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity | |
Harris Jr et al. | Successful integration of hepatitis C evaluation and treatment services with methadone maintenance | |
Cunningham et al. | Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people who inject drugs | |
Choi et al. | Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B | |
US Preventive Services Task Force* | Screening for hepatitis C virus infection in adults: recommendation statement | |
McPherson et al. | Targeted case finding for hepatitis B using dry blood spot testing in the British–Chinese and South Asian populations of the North‐East of England | |
Wang et al. | Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir | |
McGovern et al. | Acute hepatitis C virus infection in incarcerated injection drug users | |
Sølund et al. | Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation | |
Min Thaung et al. | Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus‐co‐infected patients in Myanmar |